EDAP TMS S.A ROE 2012-2025 | EDAP
Current and historical return on equity (ROE) values for EDAP TMS S.A (EDAP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| EDAP TMS S.A ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.02B | $0.03B | -60.43% |
| 2025-06-30 | $-0.02B | $0.03B | -55.00% |
| 2025-03-31 | $-0.02B | $0.04B | -51.69% |
| 2024-12-31 | $-0.02B | $0.04B | -42.42% |
| 2024-09-30 | $-0.02B | $0.05B | -43.84% |
| 2024-06-30 | $-0.02B | $0.05B | -35.74% |
| 2024-03-31 | $-0.02B | $0.06B | -30.04% |
| 2023-12-31 | $-0.02B | $0.06B | -32.71% |
| 2023-09-30 | $-0.02B | $0.06B | -31.10% |
| 2023-06-30 | $-0.02B | $0.07B | -24.66% |
| 2023-03-31 | $-0.01B | $0.07B | -15.83% |
| 2022-12-31 | $0.00B | $0.08B | -4.60% |
| 2022-09-30 | $0.00B | $0.07B | 6.64% |
| 2022-06-30 | $0.00B | $0.06B | 5.36% |
| 2022-03-31 | $0.00B | $0.06B | 0.00% |
| 2021-12-31 | $0.00B | $0.06B | 1.98% |
| 2021-09-30 | $0.00B | $0.06B | 0.00% |
| 2021-06-30 | $0.00B | $0.06B | 0.00% |
| 2021-03-31 | $0.00B | $0.03B | 4.30% |
| 2020-12-31 | $0.00B | $0.03B | -6.56% |
| 2020-09-30 | $0.00B | $0.03B | -20.00% |
| 2020-06-30 | $0.00B | -12.90% | |
| 2020-03-31 | $0.00B | 12.90% | |
| 2019-12-31 | $0.00B | $0.03B | 25.81% |
| 2019-09-30 | $0.00B | 55.17% | |
| 2019-06-30 | $0.00B | 27.59% | |
| 2019-03-31 | $0.00B | -6.90% | |
| 2018-12-31 | $0.00B | $0.03B | -6.90% |
| 2018-09-30 | $0.00B | -14.04% | |
| 2018-06-30 | $0.00B | $0.03B | -14.04% |
| 2018-03-31 | $0.00B | -21.43% | |
| 2017-12-31 | $0.00B | $0.03B | -7.14% |
| 2017-09-30 | $0.00B | -14.55% | |
| 2017-06-30 | $0.00B | $0.03B | 0.00% |
| 2017-03-31 | $0.01B | 36.36% | |
| 2016-12-31 | $0.01B | $0.03B | 36.36% |
| 2016-09-30 | $0.01B | 109.09% | |
| 2016-06-30 | $0.01B | $0.03B | 54.55% |
| 2016-03-31 | $0.00B | 51.61% | |
| 2015-12-31 | $0.00B | $0.02B | -12.90% |
| 2015-09-30 | $-0.01B | $0.00B | -114.29% |
| 2015-06-30 | $0.00B | $0.02B | 45.71% |
| 2015-03-31 | $0.00B | $0.00B | -45.71% |
| 2014-12-31 | $0.00B | $0.02B | 0.00% |
| 2014-09-30 | $0.00B | 29.63% | |
| 2014-06-30 | $-0.01B | $0.02B | -103.70% |
| 2014-03-31 | $0.00B | 0.00% | |
| 2013-12-31 | $-0.01B | $0.01B | -80.00% |
| 2013-09-30 | $-0.01B | -85.71% | |
| 2013-06-30 | $-0.01B | $0.01B | -71.79% |
| 2013-03-31 | $-0.01B | $0.01B | -97.56% |
| 2012-12-31 | $-0.01B | $0.01B | -66.67% |
| 2012-09-30 | $-0.01B | $0.01B | -64.29% |
| 2012-06-30 | $-0.01B | $0.02B | -48.28% |
| 2012-03-31 | $-0.01B | $0.02B | -43.64% |
| 2011-12-31 | $0.00B | $0.01B | -15.69% |
| 2011-09-30 | $-0.01B | $0.01B | -86.27% |
| 2011-06-30 | $-0.01B | $0.01B | -109.80% |
| 2011-03-31 | $-0.01B | $0.01B | -100.00% |
| 2010-12-31 | $-0.02B | $0.01B | -128.30% |
| 2010-09-30 | $-0.01B | $0.01B | -33.90% |
| 2010-06-30 | $-0.01B | $0.01B | -70.97% |
| 2010-03-31 | $-0.01B | $0.02B | -64.71% |
| 2009-12-31 | $-0.01B | $0.02B | -61.11% |
| 2009-09-30 | $-0.01B | $0.02B | -40.51% |
| 2009-06-30 | $-0.01B | $0.02B | -29.63% |
| 2009-03-31 | $0.00B | $0.02B | -18.18% |
| 2008-12-31 | $0.00B | $0.03B | 8.51% |
| 2008-09-30 | $-0.01B | $0.02B | -26.97% |
| 2008-06-30 | $0.00B | $0.03B | -8.60% |
| 2008-03-31 | $0.00B | $0.03B | -17.58% |
| 2007-12-31 | $-0.01B | $0.02B | -35.56% |
| 2007-09-30 | $-0.01B | $0.02B | -25.53% |
| 2007-06-30 | $-0.01B | $0.02B | -20.41% |
| 2007-03-31 | $-0.01B | $0.02B | -21.28% |
| 2006-12-31 | $0.00B | $0.02B | -17.78% |
| 2006-09-30 | $0.00B | $0.03B | -13.64% |
| 2006-06-30 | $0.00B | $0.02B | -19.35% |
| 2006-03-31 | $0.00B | $0.02B | -19.05% |
| 2005-12-31 | $0.00B | $0.02B | -18.18% |
| 2005-09-30 | $0.00B | -33.33% | |
| 2005-06-30 | $0.00B | -16.67% | |
| 2005-03-31 | $0.00B | -33.33% | |
| 2004-12-31 | $0.00B | $0.02B | -33.33% |
| 2004-09-30 | $-0.01B | -100.00% | |
| 2004-06-30 | $-0.01B | -116.67% | |
| 2004-03-31 | $-0.01B | -133.33% | |
| 2003-12-31 | $-0.01B | $0.02B | -166.67% |
| 2003-09-30 | $-0.01B | -93.33% | |
| 2003-06-30 | $-0.01B | -53.33% | |
| 2003-03-31 | $-0.01B | -30.11% | |
| 2002-12-31 | $0.00B | $0.03B | -12.90% |
| 2002-09-30 | $0.00B | $0.03B | 12.50% |
| 2002-06-30 | $0.01B | $0.03B | 24.49% |
| 2002-03-31 | $0.02B | $0.03B | 78.35% |
| 2001-12-31 | $0.02B | $0.03B | 115.15% |
| 2001-03-31 | $0.01B | 150.00% | |
| 2000-12-31 | $0.01B | $0.03B | 137.50% |
| 2000-09-30 | $0.00B | -53.33% | |
| 2000-06-30 | $-0.01B | -133.33% | |
| 2000-03-31 | $-0.01B | -133.33% | |
| 1999-12-31 | $0.00B | $0.02B | -106.67% |
| 1999-09-30 | $-0.01B | -90.91% | |
| 1999-06-30 | $-0.01B | -145.45% | |
| 1999-03-31 | $-0.01B | -127.27% | |
| 1998-12-31 | $-0.01B | $0.02B | -145.45% |
| 1998-09-30 | $-0.01B | 0.00% | |
| 1998-06-30 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.168B | $0.069B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.576B | 25.44 |
| Intuitive Surgical (ISRG) | United States | $178.066B | 68.04 |
| IDEXX Laboratories (IDXX) | United States | $51.073B | 48.94 |
| Edwards Lifesciences (EW) | United States | $47.962B | 32.16 |
| IQVIA Holdings (IQV) | United States | $39.378B | 21.96 |
| Alcon (ALC) | Switzerland | $39.263B | 26.46 |
| Mettler-Toledo (MTD) | United States | $28.306B | 33.12 |
| DexCom (DXCM) | United States | $28.288B | 38.99 |
| STERIS (STE) | Ireland | $25.934B | 26.77 |
| Waters (WAT) | United States | $22.587B | 29.87 |
| Coloplast (CLPBY) | Denmark | $18.987B | 32.40 |
| Hologic (HOLX) | United States | $16.685B | 17.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.055B | 0.00 |
| Penumbra (PEN) | United States | $13.981B | 98.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.101B | 10.86 |
| Globus Medical (GMED) | United States | $12.005B | 25.20 |
| SARTORIUS (SSSGY) | Germany | $7.821B | 45.42 |
| Masimo (MASI) | United States | $7.435B | 23.82 |
| Glaukos (GKOS) | United States | $6.747B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.917B | 18.80 |
| TransMedics (TMDX) | United States | $4.579B | 54.25 |
| Teleflex (TFX) | United States | $4.568B | 7.28 |
| LivaNova (LIVN) | United Kingdom | $3.645B | 19.69 |
| Veracyte (VCYT) | United States | $3.017B | 34.38 |
| Integer Holdings (ITGR) | United States | $2.998B | 14.07 |
| Elekta AB (EKTAY) | Sweden | $2.282B | 21.34 |
| Alphatec Holdings (ATEC) | United States | $2.152B | 0.00 |
| UFP Technologies (UFPT) | United States | $1.973B | 26.06 |
| Artivion (AORT) | United States | $1.953B | 89.63 |
| Nihon Kohden (NHNKY) | Japan | $1.915B | 16.72 |
| PROCEPT BioRobotics (PRCT) | United States | $1.628B | 0.00 |
| AxoGen (AXGN) | United States | $1.615B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.362B | 0.00 |
| IRadimed (IRMD) | United States | $1.259B | 60.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.929B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.869B | 4.71 |
| SiBone (SIBN) | United States | $0.710B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.642B | 37.31 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.625B | 12.47 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.603B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.590B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.533B | 0.00 |
| NeuroPace (NPCE) | United States | $0.530B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.445B | 12.27 |
| OrthoPediatrics (KIDS) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.429B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.376B | 0.00 |
| RxSight (RXST) | United States | $0.363B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 58.71 |
| Sight Sciences (SGHT) | United States | $0.340B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.276B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| CVRx (CVRX) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.186B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.178B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.128B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.120B | 0.00 |
| Hyperfine (HYPR) | United States | $0.113B | 0.00 |
| Solana (HSDT) | United States | $0.103B | 0.00 |
| Accuray (ARAY) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| DarioHealth (DRIO) | United States | $0.074B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |